Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Slugg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JAMA|July 13, 1970
Complications of methysergide therapy: retroperitoneal fibrosis, mitral regurgitation, edema, and hemolytic anemiaP H Slugg, R S Kunkel
Cleveland Clinic Quarterly|July 1, 1970
Alport's syndrome (hereditary nephritis); report of six cases and review of the literatureP H Slugg, D C Humphrey
Cleveland Clinic Quarterly|January 1, 1985
Theophylline and its interactionsP H Slugg, C E Pippenger
Archives of Internal Medicine|November 1, 1992
Ranitidine pharmacokinetics and adverse central nervous system reactionsP H Slugg, M T Haug, C E Pippenger
Southern Medical Journal|May 1, 1983
Listeria monocytogenes endocarditis on a prosthetic heart valveT L Higgins, J A Mallek, P H Slugg
Contributions to Nephrology|January 1, 1991
Comparative vancomycin kinetics in intensive care unit patients with acute renal failure: intermittent hemodialysis versus continuous hemofiltration hemodialysisP H Slugg, M T Haug, C Bosworth, et al.
Journal of Clinical Pharmacology|April 17, 2001
Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteersA Sharma, P H Slugg, J L Hammett, et al.
Pharmaceutical Research|December 2, 1998
Estimation of oral bioavailability of a long half-life drug in healthy subjectsA Sharma, P H Slugg, J L Hammett, et al.
Journal of Clinical Pharmacology|April 13, 2000
Cirrhosis does not affect the pharmacokinetics and pharmacodynamics of clopidogrelP H Slugg, D R Much, W B Smith, et al.
Cleveland Clinic Quarterly|January 1, 1985
Necrolytic migratory erythema-like dermatitis with malabsorptionR E Ranchoff, G R kantor, P H Slugg, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA|July 13, 1970
Complications of methysergide therapy: retroperitoneal fibrosis, mitral regurgitation, edema, and hemolytic anemiaP H Slugg, R S Kunkel
Cleveland Clinic Quarterly|July 1, 1970
Alport's syndrome (hereditary nephritis); report of six cases and review of the literatureP H Slugg, D C Humphrey
Cleveland Clinic Quarterly|January 1, 1985
Theophylline and its interactionsP H Slugg, C E Pippenger
Archives of Internal Medicine|November 1, 1992
Ranitidine pharmacokinetics and adverse central nervous system reactionsP H Slugg, M T Haug, C E Pippenger
Southern Medical Journal|May 1, 1983
Listeria monocytogenes endocarditis on a prosthetic heart valveT L Higgins, J A Mallek, P H Slugg
Contributions to Nephrology|January 1, 1991
Comparative vancomycin kinetics in intensive care unit patients with acute renal failure: intermittent hemodialysis versus continuous hemofiltration hemodialysisP H Slugg, M T Haug, C Bosworth, et al.
Journal of Clinical Pharmacology|April 17, 2001
Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteersA Sharma, P H Slugg, J L Hammett, et al.
Pharmaceutical Research|December 2, 1998
Estimation of oral bioavailability of a long half-life drug in healthy subjectsA Sharma, P H Slugg, J L Hammett, et al.
Journal of Clinical Pharmacology|April 13, 2000
Cirrhosis does not affect the pharmacokinetics and pharmacodynamics of clopidogrelP H Slugg, D R Much, W B Smith, et al.
Cleveland Clinic Quarterly|January 1, 1985
Necrolytic migratory erythema-like dermatitis with malabsorptionR E Ranchoff, G R kantor, P H Slugg, et al.
Pageof 2